PrEP Uptake Attitudes Among Young Ghanaians: Study Findings

Attitudes toward and medical decisions on uptake of pre-exposure prophylaxis among young Ghanaians: A quasi-experimental one group study

Ami R. Moore, PhD, MPH, CPH1; Adobea Yaa Owusu, PhD, MPH2; Anh Ta, PhD3; Curlin Alexis, Psy. D, MPH4

  1. Department of Rehabilitation and Health Services, College of Health and Public Service, University of North Texas
  2. Institute of Statistical, Social and Economic Research, College of Humanities, University of Ghana, Legon, Accra, Ghana
  3. Department of Management, College of Business Administration, University of Nebraska Omaha
  4. Allied Health Professionals’ Council, Grenada

 

OPEN ACCESS

PUBLISHED:31 October 2024

CITATION: Moore, AR., Owusu, AY., et al., 2024. Attitudes toward and medical decisions on uptake of pre-exposure prophylaxis among young Ghanaians: A quasi-experimental one group study.
Medical Research Archives, [online] 12(10).
https://doi.org/10.18103/mra.v12i10.5676

COPYRIGHT: © 2024 European Society of Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

DOI https://doi.org/10.18103/mra.v12i10.5676

ISSN 2375-1924

 

Abstract

This study examined attitudes toward pre-exposure prophylaxis (PrEP) and medical decision making about PrEP uptake among educated young Ghanaians in Lower Manya Krobo Municipality (LMKM) to prevent HIV/AIDS. Lower Manya Krobo Municipality has a history of high HIV infection. There is paucity of studies on attitudes towards and medical decisions on PrEP among Ghanaians. PrEP is currently not approved in Ghana and West Africa generally. Efforts are, however, being made to study the possible use of the intervention in Ghana, against a background of generalized HIV infection, and increasing infection among the youth. We used primary data administered through mostly closed-ended questionnaires to 261 respondents. A quasi-experimental one group study was adopted. Respondents were asked the same questions on attitudes towards and medical decisions on PrEP before and after watching a six-minute YouTube video on PrEP. ANOVA was used to examine statistical significance between the paired, pre-and-post data. The Wilcoxon signed rank test helped with conclusions about the mean difference between the paired responses. The findings corroborated with previous literature regarding high sexual risk among the young people. There was a statistically significant effect of the video on attitudes and medical decisions regarding use of PrEP. It seemed that if PrEP were available, the study participants would uptake it to proactively protect themselves from HIV infection. They also had a higher inclination of using PrEP if a medical officer recommended its use, and its side effects were minimal. Statistically significant gendered differences showed that female respondents were less concerned about being stigmatized as having HIV if they took PrEP and were also more likely to respond favorably to the recommendation of a physician to use the intervention, compared to their male counterparts. Public education on PrEP use should consider the involvement of a medical figure.

Keywords: HIV/AIDS; pre-exposure prophylaxis (PrEP); quasi-experimental design, youth; Lower Manya Krobo Municipality; Ghana

Introduction

Pre-exposure prophylaxis (PrEP) has proven effective in reducing the spread of HIV among high-risk people who are HIV-negative. Studies indicate that when used as recommended, PrEP significantly reduces the risk of HIV acquisition 1,2. Yet several challenges prevent the utmost uptake of PrEP. Lack of awareness, knowledge of how to use PrEP, and misinformation about PrEP, even among healthcare providers, have been reported 3,4. HIV-related stigma also prevents people from practicing safer sex, including PrEP uptake 5-7. Cultural values such as disapproval of sex at a young age, and especially before marriage 8, social norms and poor social network support 9,10, and poverty 11 are also some of the barriers to an effective PrEP uptake.

In Africa, PrEP uptake has been slow despite its great need. In fact, over 50% of people living with HIV reside in Africa, and the youth, especially young women, represent one of the fastest-growing populations with HIV 11,12. Generally, African youth do not perceive themselves as at risk for HIV, and the females often do not know the serostatus of their male sexual partners 11,13. However, some PrEP programs that focus on population-specific barriers have been successful in reducing HIV risks 14,15, and particularly among women 16-18. Identifying the barriers to and facilitators of PrEP uptake and creating intervention programs that teach how to overcome the barriers and maximize hindrances to its uses are important health promotion strategies. This study uses one group quasi-experimental data to examine attitudes toward PrEP and medical decision about PrEP uptake among educated young Ghanaians in Lower Manya Krobo Municipality (LMKM), an area with an unfavorable history with HIV/AIDS 19,20. We examine the impact of a short PrEP information video endorsed by the Centers for Disease Prevention and Control 21, among some young Ghanaians, then analyze the differences between males and females, and provide some recommendations to stakeholders on ways to improve PrEP uptake among Ghanaian adolescents and young adults.

Today, HIV is no longer a death sentence because of the availability of antiretroviral drugs. However, people living with HIV still face a certain level of stigma, depending on the settings. Research studies on African populations still report stigma and discrimination against people living with HIV 22-25. Also, an important number of African young adults, especially girls, are infected with HIV every day. In fact, 63% of all new HIV infections worldwide occurred in sub-Saharan African women and girls in 2022 22.

Social vulnerability also puts young people, students, the unemployed, and women at risk of HIV in different resource-challenged settings 26-28. Social and structural factors such as poverty, gender inequality, and human rights violations all increase the likelihood of young people, students, and other vulnerable populations becoming infected with HIV 29,30. Hence, it is important to disseminate PrEP in Africa, especially among people who are at risk of becoming HIV infected.

For PrEP use to be accepted and adhered to, Machado et al. 31 advised that each country and program should research and understand the peculiar characteristics of their target populations to discover the attitudes and perceptions of people. This should be centered around what they think, how they feel, and their perspectives surrounding PrEP and risky sexual behavior. The purpose of our quasi-experimental one group study is to examine attitudes and medical decisions about PrEP among Ghanaian students aged 18-35 in LMKM. Study participants were asked to watch a video on PrEP, after collecting baseline data and then post-intervention data were collected. The study is guided by the following questions: 1. Will watching the video change attitudes toward PrEP uptake among students? 2. Will watching the video change students’ medical decisions about PrEP? 3. Will there be any differences between male and female students after watching the video?

Setting

Lower Manya Krobo Municipality (LMKM) is in the southeastern area in Ghana. It had a population of 121,478 in 2021 32. Agriculture is the main economic activity. LMKM is of particular interest because it has led in the rates of the HIV infection in Ghana nearly all the time 19,33. For instance, in 2018, the HIV/AIDS prevalence rate was 2.66% nationally while it was 5.6% in LMKM 33,34. Also, HIV prevalence in LMKM was reported to be over 1.7 above the national average among Ghanaians aged 15 to 49 in 2022 35. Given its HIV history, the Ghanaian government has established HIV testing, counselling, treatment, and referral facilities and specially trained personnel in the municipality 36,37. It is important to note that some previous authors have attributed the high rates of HIV/AIDS in the study catchment area to economic insecurity and reverse social disorganisation due to the entrenched effect of HIV/AIDS in the area over time 38-40.

Methods

STUDY DESIGN AND SAMPLING

A population of ten post-basic schools were in the study’s catchment area at the time of data collection. A pre-data collection recognizance survey was conducted to visit all post-basic schools in the study district/municipality, and to explain details of the study to identified heads/owners of each school. In Ghana, a post-basic school is a school that enrolls students beyond the first nine years of formal schooling, excluding kindergarten. During the visits, approved Institutional Review Board (IRB) documents, a brief synopsis of the study’s proposal, and the draft questionnaire were shown to and left with the heads of each school. The Proprietor of a female-only school declined for her students to participate in the study, citing concerns of parents on talking to their children about sex-related issues. The remaining nine schools were used, after permission had been granted by the respective school authorities.

Post-basic, in-school young people were used because PrEP was not in use officially in Ghana at the time of the study and it was reasoned that in-school population may have a higher probability to have read about it, given the proliferation of smart phones and internet at school, compared with out-of-school youth. The inclusion criteria were for a student to be aged 18-35 years (the delineation of ‘youth’ by Ghana’s Youth Policy), consent to be part of the study, and for the school’s Proprietor or Head to agree for the study to be undertaken in their school. IRB approvals of the study were obtained from both the University of North Texas and the University of Ghana, Legon’s Ethical Committee for the Humanities.

Sampling for the study was combined purposive, quota and random—based initially on the number of students enrolled in each consenting school, and the male-female ratio for each co-ed school. Students were initially informed of the study by the schools’ Head or Proprietor. Those who consented to be part of it were initially assembled, screened for age, and randomly selected to fit the number of males and females needed per school. Selected students were grouped in a big classroom for each school, and briefed about the study, without the school authorities being present. They were informed that the study was voluntary, there would be no penalty for opting out of it, and could opt out anytime they choose to, even if they started. No student opted out at that stage. Then they were asked to sign the consent forms.

After this, each student was seated comfortably on a chair with a desk and spaced from their other schoolmates. The students self-administered the first part of the questionnaire, after which a short YouTube video that explains PrEP and its utility was shown to them as a group. The same questions were answered after watching the video. The second author and two trained, post-graduate research assistants (RAs) were on standby to answer any questions that the respondents had. Pre-and post-data were collected from a sample of 261 students in April 2019. Participants were at least 18 years old and fluent in English. A series of statements (see Tables 2 and 3) that assessed participants’ willingness towards and medical decision on uptake of PrEP were used for this study. The second author and two trained post-graduate RAs collected the data. It took on average 47 minutes to complete the pre-and post-treatment surveys, excluding the viewing of the video clip. Participants received five Ghana cedis ($1.2) approved at the time of filing for ethical approval in August 2018 as incentive to participate in the study. This amount would be enough to buy a snack at the time of the study.

DATA ANALYSIS

The answer options for the attitudes toward PrEP and medical decision about PrEP uptake statements in Table 2 were recoded whereby Yes =3; Don’t know =2, and No = 1 for all the statements except statements #4 (I would wait until other people were taking PrEP before I use it myself) and #5 (I would be concerned that people will think I have HIV if I am taking a HIV medicine) for attitudes and statement #3 (I would be very uncomfortable taking HIV medicines when I don’t have HIV) for medical decision. We reverse coded the answer options for these 3 statements to: Yes=1, Don’t know =2, and No=3. Recoding the answer options makes it easier to understand the scores (the higher the scores, the more comfortable one was with PrEP). Reverse coding the three answer options mentioned above, participants who said yes were not comfortable with PrEP, and those who said no were more comfortable. Higher scores indicate being more comfortable with PrEP uptake.

The Wilcoxon signed rank test 41 and ANOVA between subjects were used to test whether the mean difference between the paired data was statistically significant. We used ANOVA between subjects to assess the difference between posttest scores and pretest scores for all participants to answer the research questions 1 and 2, namely, a.– Will watching the video change attitudes toward PrEP uptake among students? b.– Will watching the video change students’ medical decisions about PrEP? and between male and female participants for question 3. which is c. — Will there be any differences between male and female students after watching the video?

Results

Table 1 presents the demographic characteristics of study participants. The average age was about 20 years (20.4). They were about 18 years old (17.79) on average when they had their first sexual intercourse. They were mostly high school seniors (70.9%) and almost all the participants self-identified as heterosexuals (99.2%). While about 48% have ever had sex at the time of the study, only 10% have heard about PrEP. Most of the participants (62.4%) had had at most two sexual partners in their lifetime. Most of the study participants did not use a condom during sex in the last 6 months prior to the study (71.4%), and 12% had ever had sexually transmitted infection. About 21% (20.6%) of the participants reported to have been forced to have sex or performed sexual act on someone. Only 30% had ever been tested for HIV.

Variable N Mean/Valid %
Age in years 261 20.4
Age at first sexual intercourse 124 17.79
Educational attainment    
High school senior 183 70.9
Nursing training 41 15.9
Technical college 23 8.9
Other (not specified) 11 4.3
Have you ever had sexual intercourse?    
Yes 126 48.3
No 135 51.7
Sexual orientation    
Heterosexual 120 99.2
Bisexual 1 0.8
Number of people have ever had sex with    
1-2 78 62.4
3-4 29 23.2
5-6 7 5.6
7+ 11 4.8
Number of people have had sex with last 6 months    
0 44 34.9
1 62 49.2
2 13 10.3
3+ 7 5.6
Used condom during each sexual encounter in last 6 months?    
Yes 32 28.6
No 80 71.4
Have you ever had sexually transmitted infection?    
Yes 15 12.1
No 109 87.9
Have ever been forced to have sex or perform sexual act on someone?    
Yes 53 20.6
No 204 79.4
Have you ever been tested for HIV?    
Yes 78 30.0
No 182 70.0
Have you ever heard of PrEP?    
Yes 26 10.1
No 232 89.9

Results for the Wilcoxon signed rank tests are in Table 2. The video significantly changed participants’ attitudes and medical decisions regarding the uptake of PrEP for HIV prevention. Study participants agreed that they would be good at adhering to a daily PrEP regimen to protect themselves from HIV (pretest mean =2.04; posttest mean =2.43). They would be proactive in initiating PrEP usage if it was available (pretest mean =1.93; posttest mean =2.26). Also, they believed that taking a daily HIV medicine would be a good way to protect themselves from getting HIV (pretest mean =1.93; posttest mean =2.34). Furthermore, participants showed enhanced confidence in taking PrEP after watching the video. They would be less concerned that people would think they have HIV if they were taking PrEP (pretest mean =1.67; posttest mean =1.87) and would not wait until other people were taking PrEP before they use it themselves (pretest mean =2.11; posttest mean =2.33).

Furthermore, participants significantly became more favorable to medical decisions regarding PrEP uptake after watching the video. They displayed a greater inclination to consider taking PrEP if recommended by their doctors (pretest mean =2.34; posttest mean =2.62). They also would take PrEP if they had minor side effects and these effects went away after taking it for a few weeks (pretest mean =1.72; posttest mean =1.96). They, additionally, would be more comfortable taking PrEP if they knew just how their health would be affected (pretest mean =2.14; posttest mean =2.38). They would also be more comfortable taking HIV medicine when they don’t have HIV (pretest mean =1.64; posttest mean =1.89).

Attitude questions Mean Wilcoxon test P-Value Pretest Posttest
I would be one of the first people to use PrEP if it were available 1.93 -4.20 1.93 2.26
Taking a daily HIV medicine would be a good way to protect myself from getting HIV 1.93 -6.04 1.93 2.34
I would be very good at remembering to take a daily HIV pill to protect myself from getting HIV 2.04 -5.02 2.04 2.43
I would wait until other people were taking PrEP before I use it myself 2.11 -4.35 2.11 2.33
I would be concerned that people will think I have HIV if I am taking a HIV medicine 1.67 -3.176 1.67 1.87
If I was taking PrEP, I would feel more comfortable about having sex with someone who is HIV positive. 1.60 1.903 1.60 1.70

Medical decision questions

Medical decision questions Mean Wilcoxon test P-Value Pretest Posttest
If my doctor suggested that I take PrEP to protect myself from getting HIV I would take it 2.34 -4.20 2.34 2.62
I would take PrEP even if I had minor side effects that went away after taking it for a few weeks. 1.72 -3.75 1.72 1.93
I would be very uncomfortable taking HIV medicines when I don’t have HIV 1.64 -3.89 1.64 1.89
I would be more comfortable using PrEP if I knew just how it would affect my health 2.14 -3.62 2.14 2.38

The results in Table 3 provide an analysis of the attitudes toward and medical decisions to uptake PrEP among male and female study participants. Comparing male and female participants, results shows that only one attitude and one medical decision questions were statistically significant. More female participants agreed that they would be less concerned about people thinking that they had HIV if they were taking an HIV medicine compared to their male counterparts, after watching the video. Also, more females agreed that they would take PrEP to protect themselves from getting HIV if their doctors suggested it, compared to their male counterparts. It is worth noting that more women also agreed that they would be very good at remembering to take daily HIV pill to protect themselves from getting HIV, but the p-value is 0.065. All the other questions did not show a significant difference between the male and female participants statistically.

Attitudes toward and medical decisions to uptake PrEP among males and females (N=261) Mean Anova F test P-Value
I would be one of the first people to use PrEP if it were available 0.26 0.175 0.676
Taking a daily HIV medicine would be a good way to protect myself from getting HIV 0.45 0.230 0.633
I would be very good at remembering to take a daily HIV pill to protect myself from getting HIV 0.22 3.423 0.065
I would wait until other people were taking PrEP before I use it myself. 0.33 1.772 0.184
I would be concerned that people will think I have HIV if I am taking a HIV medicine 0.06 1.078 0.001
If I was taking PrEP, I would feel more comfortable about having sex with someone who is HIV positive 0.17 0.631 0.428

Discussion

Many studies have examined knowledge of and attitudes toward PrEP in Africa, but most of the studies have been conducted among people in southern and eastern African countries 8,11,42-45 and among men who have sex with men 7,46. This study uses a one-group quasi-experimental design to assess attitudes toward and medical decisions on the uptake of PrEP among young Ghanaian adults in LMKM, an area with an unfavorable HIV prevalence. The LMKM stands out in the debilitating effect of HIV/AIDS on the socio-economic fabric and livelihoods of residents in the catchment area. Findings in this study aim to add to the sparse literature on PrEP uptake in West Africa, especially Ghana. While the study participants mostly came from a population with an HIV unfavorable history, they had a low level of PrEP knowledge. Nevertheless, PrEP is currently not in use in Ghana. Thus, not knowing about it practically takes nothing away from them, with respect to its potential to have been of benefit to protecting them against infection with the virus. However, watching the video increased their knowledge and led to some positive attitudes toward PrEP uptake and making medical decisions with regards to possible uptake of PrEP. The video with information on PrEP thus, served as a critical intervention to their possible safety, if it were in use, and provides a policy nuance for Ghana’s decision regarding the use of PrEP. For instance, our participants would be proactive in initiating PrEP usage if it was available. They also displayed a greater inclination to consider taking PrEP if recommended by their doctors. The pointers to the influence of a recommendation by a physician underscore the effect of credible information. Physicians are in fact, trained to have command over their recommendations for medications and patient safety, ordinarily.

Hence, public education on PrEP may go a long way to improve the odds of Ghanaian young adults and women who are at risk of getting HIV if PrEP is introduced in the country. Awareness of PrEP may also increase among all population groups, especially, among at-risk populations. A possible introduction of the intervention in Ghana to aid the fight against HIV/AIDS is also warranted as there is a generalized HIV/AIDS epidemic (more than 1% of the general population are infected) and as PrEP is known to have aided HIV infection control in countries in which it is in use 47.

Conversely, while respondents of this study would be one of the initiators to use PrEP if available and would be less likely to wait until others were taking PrEP before they use it themselves, it is important to note that the uptake of PrEP is a complex decision to be made and people who show high level of interest may still not be ready for it. As indicated by Rolle et al. 48, showing high interest in PrEP does not necessarily mean following up with uptake. In fact, in their study of young Black MSMs in Atlanta, Georgia, even when structural barriers are lifted, uptake of PrEP was still low among people who showed high interest in uptake.

In drug administration typically, issues such as potential side effects, prescription-related control, access-related issues such as access to a health facility and to qualified technical persons to do the prescription, as well as financial access and geographical access to a place where the medicine of interest is available for retail are all important. In Ghana, these types of healthcare-related access do not come on a silver platter, particularly for young, unemployed persons in a typically lowly endowed financial community.

It is also critically important to note that the discourse regarding PrEP use has connotations for sexual involvement, in our part of the world where HIV is mostly acquired through sexual intercourse. In this regard, the Ghanaian cultural narrative is caught up in a double wedge where young persons are stigmatized for being sexually involved, and at the same time, some of them are known to be highly sexually experienced even to the point of engaging in sexual risk that puts them in danger of contracting sexually transmitted diseases, including HIV 8. Hence it is important for stakeholders to bear this in mind and strategically work with young Ghanaians who are at risk of HIV to understand not only the benefits of PrEP but also ways to reduce barriers for PrEP uptake.

Further, the gendered difference in our findings whereby more females than males would take PrEP to protect themselves from getting HIV if their doctors suggested it speaks to the reality of females facing stiffer social backlash on being infected with HIV, and specifically so in the study areas 25,36,49. This implies higher vulnerability of females and may underscore the higher need for females to take advantage of PrEP to protect themselves against HIV infection. Furthermore, young females in Africa, Ghana, and for that matter, the study district, are more exploited sexually and thus face greater sexual risk from HIV infection 27,50. The study community we used is also more patriarchal 19,25,36,51, possibly explaining the young females’ higher propensity to use PrEP if a doctor recommended it, compared to their male counterparts. In Ghana, doctors, particularly those practicing in rural and peri-urban areas such as the study’s catchment area, are mostly males. Listening to the voice of a male doctor, and in the same vein, needing a voice to lead the females in the study to consider using PrEP attest to the mostly patriarchal culture of the study community.

While most attitudes and medical decisions regarding PrEP uptake did not show significant gender differences, concerns about stigma and adherence to medical advice were notably different, with females being less concerned about stigma and having higher likelihood of following medical recommendations compared to their male counterparts. These insights can inform targeted interventions to address specific concerns and improve PrEP uptake across different genders. In this study, more females being less concerned about possible HIV-related stigma is interesting because previous authors who have studied HIV-related issues in the study’s catchment area have noted literally the absence of HIV-related stigma for the male respondents, while the reverse was true for their female respondents 36,49. Future studies may have to unravel the nuances underlying HIV-related gender differences in stigmatization and PrEP uptake in the study area, if not for Ghana as a whole.

Limitations of the study

The main limitation of the study is that it is both retrospective and prospective. Respondents may have forgotten details of past lifestyle events they reported. Similarly, when experienced in the true setting, they may act differently from what they said, regarding the possible use of PrEP. Also, the study is cross-sectional, hence it is not possible to make attribution to causality in the findings. Furthermore, the purposive sampling makes our findings lack external validity to non-respondents outside the study municipality including, out-of-school youth, even within the study municipality 25,36,49. Finally, social desirability may be in effect whereby study participants gave answers that they felt would be helpful for the study and/or might be socially accepted.

Conclusion

This study examined attitudes toward PrEP and medical decision making about PrEP uptake among educated young Ghanaians in the LMKM catchment area in the Eastern Region of Ghana. PrEP is currently not in use in Ghana. However, attempts are being made to study its implications for Ghana’s fight against its generalized HIV/AIDS pandemic. This is against the background of high proportion of HIV/AIDS infections in sub-Sahara Africa in general, and particularly the increasing significantly higher infections among the youth aged 15-24 years, in the sub-region 35,52. In conclusion, our study has affirmed previous researchers in the region, that the sexual lifestyle of many young people is very risky and careless 53,54. Thus, the option of having PrEP for preventing HIV-infection would be necessary.

Our quasi-experimental one group approach found that effective health education on PrEP would go a long way in facilitating the adoption and use of PrEP among Ghanaian youth. This should include education on its side effects, which effects should be minimal, etc. Furthermore, recommending PrEP by a physician would greatly boost the chances of its acceptance among the respondents. Importantly, we found some statistically significant attitudinal differences between male and females. Compared to males, females were less concerned about being stigmatized for having HIV should they be seen to be taking PrEP. Also, compared to the male participants, females had more positive attitudes towards taking PrEP to protect themselves against HIV, on the recommendation of their physician. This gender differences may be informed by documented gendered differences in experiencing HIV/AIDS in Ghana, including the study municipality 19,25,36.

Before Ghanaian health authorities take a policy decision on adopting PrEP, there is the need for widespread, effective health education and further studies among both the general public and key populations affected by HIV/AIDS. This should include information on the potential side effects of the intervention. Actively involving physician-figures in mass media and small-group based social and behavioral health communication and education on PrEP is highly recommended when the time comes to implement PrEP in Ghana.

Declarations of Competing Interests:

The authors declare no competing interests.

Funding: Not applicable

Acknowledgement: Not applicable

Consent for publication: All authors have read and approved the manuscript.

References

  1. McCormack S, Dunn DT, Desai M, et al. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomized trial. Lancet 2016:387(100013):53-60. https://doi.org/10.1016/S0140-6736(15)00056-2
  2. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine 2012:367:399-410. Doi:10.1056/NEJMoa1108524.
  3. Zhang L, Song Y, Zheng X, Liu Y & Chen H. The experience of healthcare workers to HIV pre-exposure prophylaxis (PrEP) implementation in low-and middle-income countries: A systematic review and qualitative meta-synthesis. Frontiers in Public Health 2023;11:1224461. doi:10.3389/fpubh.2023.1224461.
  4. Davey DL, Daniels J, Beard C, et al,. Healthcare provider knowledge and attitudes about pre-exposure prophylaxis (PrEP) in pregnancy in Cape Town, South Africa. AIDS Care 2020;32(10):1290-1294. Doi:10.1080/09540121.2020.1782328
  5. Golub SA. PrEP stigma: Implicit and explicit drivers of disparity. Current HIV/AIDS Rep, 2018;2:190-197. Doi:10.1007/s11904-018-0385-0.
  6. Gyamerah AO, Kinzer E, Aidoo-Frimpong G, et al. PrEP knowledge, acceptability, and implementation in Ghana: Perspectives of HIV service providers and NSM, trans, women, and gender diverse individuals living with HIV. PLOS Global Public Health 2023;3(6):e0001956. https://doi.org/10.1371/journal.pgph.0001956
  7. Reyniers T, Babo SAY, Ouedraogo M, et al. Strategies to improve PrEP uptake among West African men who have sex with men: A multi-country qualitative study. Frontiers in Public Health 2023;11:1165327. https://doi.org/10.3389/fpubh.2023.1165327
  8. Muhumuza R, Ssemata AS, Kakande A, et al. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Archives of Sexual Behavior 2021;50:1729-1742. Doi:10.1007/s10508-020-01880-y
  9. Giovenco D, Gill K, Fynn L, et al. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence. PLoS One 2021;16(3):e0248307. Doi:10.1371/journal.pone.0248307 https://doi.org/10.1371/journal.pone.0248307 PMID: 33667264
  10. Pintye J, Beima-Sofie KM, Makabong OP, et al. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy. AIDS Patient Care STDS 2018;32(12):538–44. https://doi.org/10.1089/apc.2018.0058
  11. Jackson-Gibson M, Ezema A, Orero W, et al. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health 2021;21:1284. https://doi.org/10.1186/s12889-021-11335-12
  12. Karim S & Baxter C. HIV pre-exposure prophylaxis implementation in Africa: Some early lessons. The Lancet 2021;9: e1634-e1635. https://doi.org/10.1016/S2214-109X(21)00460-5
  13. Mugo NR, Ngure K, Kiragu M, Irungu E & Kilonzo N. PrEP for Africa: What we have learnt and what is needed to move to program implementation. Current Opinion HIV AIDS 2016;11(1):80-86. Doi:10.1097/COH.0000000000000224
  14. Koss CA, Havlir DV, Ayieko J, et al. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. PLOS Medicine 2021;18(2):e1003492. https://doi.org/10.1371/journal.pmed.1003492
  15. Masyuko S, Mukui I, Njathi O, et al. PrEP roll out in a national public sector program: The Kenyan case study. Sexual Health 2018;15(6):578-586. DOI:10.1071/SH18090
  16. Cassidy T, Ntuli N, Kilani C, et al. Delivering PrEP to young women in a low-income setting in South Africa: Lessons for providing both convenience and support. AIDS and Behavior 2022, 26, 147-159. https://doi.org/10.1007/s10461-021-03366-x
  17. Rousseau E, Baeten J, Morton J. et al. Association between contraceptive use and PrEP uptake and continuation in adolescent girls and young women in Cape Town, South Africa. Abstract, IAS 2019; Mexico City, Mexico. Retrieved at: https://www.prepwatch.org/wp-content/uploads/2022/03/IAS2019_Rousseau_PrEPandContraception.pdf
  18. Rousseau E, Bekker L, Julies R et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Services Research 2021;21(888). https://doi.org/10.1186/s12913-021-06920-4
  19. Owusu AY & Laar AK. Managing HIV-Positive Serostatus in Ghana’s Most HIV Concentrated District: Self-Perceived Explanations and Theoretical Discourse. African Journal of AIDS Research 2018;17(1). Doi:10.2989/16085906.2017.1419268.
  20. Tenkorang EY, Owusu AY, Laar AK & Yeboah EH. Housing, psychosocial and adherence counseling among HIV+ persons in Ghana. Health Promotion International 2019;34(2):204-214. https://doi.org/10.1093/heapro/dax072.
  21. YouTube. What is PrEP? 2017. Retrieved at: What is PrEP? – YouTube
  22. UNAIDS. Country factsheets: Ghana, 2016. 2017. Available from: http://www.unaids.org/en/regionscountries/countries/ghana
  23. Adam A, Fusheini A, Ayanore MA, et al. HIV stigma and status disclosure in three municipalities in Ghana. Annals of Global Health 2021, 87(1):49,1-12. Doi:10.5334/aogh.3120
  24. Nyblade L, Stockton M, Saalim K, et al. Using a mixed-methods approach to adapt an HIV stigma reduction intervention to address intersectional stigma faced by men who have sex with men in Ghana. Journal of the International AIDS Society 2022;25(S1):e25908. Doi:10.1002/jia2.25908.
  25. Owusu AY. Experiences of new diagnoses among HIV-positive persons: implications for public health. BMC Public Health 2022;22:538. https://doi.org/10.1186/s12889-022-12809-6.
  26. Johnson M, Samarina A, Xi H, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care 2015;27(10):1220-1230. Doi:10.1080/09540121.
  27. Ramjee G & Daniels B. Women and HIV in Sub-Saharan Africa. AIDS Research and Therapy 2013;10(30). https://doi.org/10.1186/1742-6405-10-30
  28. Birdthistle I, Tanton C, de Graaf K, Schaffnit SB, Tanser F & Slaymaker E. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: A systematic review and meta-analysis. Lancet Global Health 2019;7:e1521-1540. Doi:10.1016/S2214-109X(19)30410-3.
  29. Lewis L, Khaesany AB, Humphries H. et al. (2022). HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study. PLOS One 2022;17(12):e0279289. https://doi.org/10.1371/journal.pone.0279289
  30. Centers for Disease Control and Prevention. Preventing HIV in youth: Successes and challenges in 15 sub-Saharan countries. 2023 Retrieved at: https://www.cdc.gov/globalhivtb/who-we-are/success-stories/success-story-pages/preventing-hiv-among-african-youth.html
  31. Machado DA, Carvalho A & Riera R. Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives, Adolescent Health, Medicine and Therapeutics 2017;137-148, Doi:10.2147/AHMT.S112757
  32. Ghana Statistical Service Population and Housing Census. Summary Report of Final Results. 2021. Retrieved at https://census2021.statsghana.gov.gh/.
  33. Ofori M, Nyame EA & Eshun I. Students’ knowledge and sources of information on HIV/AIDS: Evidence from Lower Manya Krobo municipality of the Eastern region of Ghana. Universal Journal of Social Science and Humanities 2022;2(4):186-200. Doi:10.31586/ujssh.2022.390
  34. Ghana AIDS Commission. National and sub-National HIV and AIDS estimates and projections. 2019. Retrieved at: https://www.ghanaids.gov.gh/mcadmin/Uploads/2019%20National%20and%20Sub-National%20Estimates%20and%20Projections%20Dissemination%2021.07.2020.pdf
  35. Ghana AIDS Commission/Citinewsroom.com. Ghana’s HIV Fact Sheet 2022. 2023. Available at: https://citinewsroom.com/wp-content/uploads/2023/08/2022_HIV_Estimates_Fact_Sheetfinal.pdf. (Accessed February 24, 2023).
  36. Owusu AY. A gendered analysis of living with HIV/AIDS in the Eastern region of Ghana. BMC Public Health 2020;20:75. https://doi.org/10.1186/s12889-020-08702-9
  37. Teye-kau M, Tenkorang EY, & Adjei PB. Revisiting the housing-health relationship for HIV-positive persons: Qualitative evidence from Lower Manya Krobo District, Ghana. Qualitative Health Research 2018;28:1217-1228. Doi:10.1177/1049732318764646
  38. Langmagne S. High HIV/AIDS prevalence in a suburban area in Ghana: A context analysis of its relationship to human trafficking. Ph.D Thesis. Sociology Department. University of Saskatchewan, Canada. 2016. Retrieved at http://hdl.handle.net/10388/7279
  39. Lund R, Agyei-Mensah S. Queens as mothers: the role of the traditional safety net of care and support for HIV/AIDS orphans and vulnerable children in Ghana. Geography Journal 2008;7193-106. Doi:10.1007/s10708-008-9145-9.
  40. Owusu AY, Teye-Kau M, & Tenkorang EY. The contexts of housing stability and change among HIV-positive persons in the Lower Manya Krobo Municipality, Ghana. Health Promotion International 2021;36(2):384-396. Doi:10.1093/heapro/daaa062.
  41. Wilcoxon F. Individual Comparisons by Ranking Methods. Biometrics Bulletin 1945;1(6):80–83. https://doi.org/10.2307/3001968
  42. Irungu EM, Mugwanya KK, Mugo NR, et al. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: A pragmatic stepped-wedge randomized trial. The Lancet 2021;9:e1730-e1739. Doi:10.1016/S2214-109X(21)00391-0.
  43. Wyatt MA, Pisarski EE, Kriel Y. Influences on PrEP uptake and adherence among South African women during periconception and pregnancy: A qualitative analysis. AIDS & Behavior 2023;27(1):208-217. Doi:10.1007/s10461-022-03757-8
  44. Beesham I, Milford C, Smit J, et al. Post-trial access to use of pre-exposure prophylaxis in Durban, South Africa. BMC Public Health 2023;23:1210. https://doi.org/10.1186/s12889-023-16139-z
  45. Koss CA, Charlebois ED, Ayieko J, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. The Lancet 2020, 7, e249-e261. https://doi.org/10.1016/S2352-3018(19)30433-3
  46. Wahome E, Graham SM, Thiong’o A, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine 2020;26:10054. https://doi.org/10.1016/j.eclinm.2020.100541
  47. Centers for Disease Control and Prevention. Pre-Exposure Prophylaxis (PrEP). 2022. Available from: https://www.cdc.gov/hiv/risk/prep/index.html (Accessed Feb 26, 2024).
  48. Rolle C, Rosenberg ES, Siegler AJ, et al. Challenges in translating PrEP interest into uptake in an observational study of young Black MSM. Journal of Acquired Immune Deficiency Syndrome 2017;76(3):250-258. Doi:10.1097/QAI.0000000000001497.
  49. Owusu AY. Social contexts of living with HIV/AIDS in the Eastern Region of Ghana. İstanbul Üniversitesi Sosyoloji Dergisi. Istanbul University Journal of Sociology 2019;39(2):425-454. https://doi.org/10.26650/SJ.2019.39.2.0109.
  50. Mufune P. Poverty and HIV/AIDS in Africa: Specifying the connections. Social Theory and Health 2015, 13(1), 1-29. https://doi.org/10.1057/sth.2014.14
  51. Sedziafa AP, Tenkorang EY, Owusu AY. Kinship and intimate partner violence against married women in Ghana: a qualitative exploration. Journal of Interpersonal Violence 2016;33(14):2197-2224. Doi:10.1177/0886260515624213.
  52. UNAIDS. (2023). Global HIV & AIDS statistics — Fact sheet. Available from: https://www.unaids.org/en/resources/fact-sheet. (Accessed Feb 26, 2024).
  53. Glover E.K., Bannerman A., Pence B.W., et al. Sexual health experiences of adolescents in three Ghanaian towns. International family planning perspectives. 2003;1:32-40. Doi:10.1363/ifpp.29.032.03.
  54. Sowah BA. Risky Sexual Behaviors among Adolescents in the La-Dadekotopon Municipality of the Greater Accra Region of Ghana (Doctoral dissertation, University of Ghana). 2016.

“`

Interested in publishing your own research?
ESMED members can publish their research for free in our peer-reviewed journal.
Learn About Membership

Call for papers

Have a manuscript to publish in the society's journal?